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The main objective of this work was to develop nanoparticles (NPs) of a mucoadhesive polymer based on
chitosan for biomedical applications. Here, we developed thiolated chitosan (TCS) using thioglycolic acid
(TGA) and chitosan in the presence of 1-ethyl-3-3(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDC) as catalyst. The prepared TCSwas characterized using FT-IR and the degree of thiol substitutionwasvailable online 21 July 2010
eywords:
hiolated chitosan
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hermal studies
found out by Ellman’smethod. The TCS nanoparticles (TCS-NPs)were developed using ionic cross-linking
reaction with pentasodium tripolyphosphate (TPP). The prepared TCS-NPs were characterized by DLS,
AFM, FT-IR, TG/DTA, etc. In vitro cytocompatibility and cell uptake studies were also carried out. These
studies suggest that the prepared NPs show less toxicity towards normal and cancer cells and they are
easily taken up by both the normal and cancer cells. So the prepared TCS-NPs could be used for drug and
s.ytocompatibility
rug delivery
gene delivery application
. Introduction
Development of bioadhesive/mucoadhesive controlled release
ystems has been the subject of many studies in recent years.
t is widely accepted that limiting the clearance by increas-
ng the viscosity of a drug formulation and also prolonging the
ontact time through mucoadhesive interactions will result in
n increased bioavailability of the drug or whatever therapeu-
ics (Margit, Constantia, & Bernkop-Schnürch, 2003). Polymeric
nhancers/mucoadhesive polymers would be a promising candi-
ate for these kinds of applications. They can act as permeation
nhancers and thereby they ﬁnd application in the oral delivery of
rotein drugs (Lichen, Jieying, Chunbai, Liming, & Cui, 2009). The
ucoadhesion, or the attachment of a natural or synthetic polymer
o a biological substrate is a practical method of drug immobi-
ization or localization and it is an important aspect of controlled
rug delivery (Wu et al., 2009). While the subject of mucoadhe-
ion is not new, there has been increased interest in recent years
n using mucoadhesive polymers for drug delivery (Ranabir, Lila,
Sontosh, 2009). Substantial effort has recently been focused on
lacing a drug or a formulation in a particular region of the body for
xtended periods of time. This is needed not only for targeting of
rugs but also for better control of systemic drug delivery (Ranabir
∗ Corresponding author. Tel.: +91 484 2801234; fax: +91 484 2802020.
E-mail addresses: rjayakumar@aims.amrita.edu, jayakumar77@yahoo.com
R. Jayakumar).
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et al., 2009) and the drugs that are absorbed through the mucosal
lining of tissues can enter directly into the blood stream and not be
inactivated by enzymatic degradation in the gastrointestinal tract
(Ranabir et al., 2009). In earlier studies, various natural and syn-
thetic polymers were explored as mucoadhesive excipients (Wu et
al., 2009). The mucoadhesive properties of these polymers or the
mechanism of mucoadhesion can be explained on the basis of for-
mation of non-covalent bonds such as hydrogen bonds and ionic
interactions between the mucoadhesive polymer and the mucus
layer (Wuet al., 2009). Several polymeric bioadhesive drugdelivery
systemshave been fabricated and studied in the past. Acrylic-based
hydrogels is an example of bioadhesive synthetic polymers which
are used for these kinds of applications (Ranabir et al., 2009).
Chitin is a biopolymer, used for various biomedical applica-
tions (Jayakumar, Nair, & Tamura, 2009). Chitosan, a biopolymer
obtained by the alkaline deacetylation of chitin, is used in the
current work. This is a natural polysaccharide of -(1,4)-linked
2-amino-2-deoxy-d-glucopyranose. Because of its biocompatibil-
ity and biodegradation properties (Bernkop-Schnürch, Schwarz, &
Steininger, 1999; Jayakumar, Chennazhi, et al., 2010; Jayakumar,
Deepthy, Manzoor, Nair, & Tamura, 2010; Jayakumar, Nwe, Tokura,
& Tamura, 2007; Jayakumar, Prabaharan, Nair, & Tamura, 2010;
Jayakumar, Prabaharan, Nair, Tokura, et al., 2010; Jayakumar,
Reis, & Mano, 2007), it has been used in a variety of biomedi-
cal applications. A number of clinical studies using chitosan have
been reported including its use as cell scaffolds in tissue engi-
neering, nerve regeneration tubes, cartilage regeneration (Freier,
Koh, Kazazian, & Shoichet, 2005; Khor and Lim, 2003; VandeVord
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t al., 2002) and also in drug delivery applications (Anitha et
l., 2009; Dev, Binulal, et al., 2010; Dev, Jithin, et al., 2010;
ayakumar, Chennazhi, et al., 2010; Jayakumar, Deepthy, et al.,
010; Jayakumar, Prabaharan, Nair, & Tamura, 2010; Jayakumar,
rabaharan, Nair, Tokura, et al., 2010; Jayakumar, Nwe, et al., 2007;
ayakumar, Prabaharan, Reis, & Mano, 2005; Jayakumar, Reis, &
ano, 2006; Mathew et al., 2010). Furthermore, it has been used
xtensively as abiomaterial, owing to its immunostimulatoryactiv-
ties (Mwale et al., 2005), anticoagulant properties, antimicrobial
ndantifungal action (Gorbachet al., 1994;Rabea, Badawy, Stevens,
magghe, & Steubaut, 2003) and for its action as a promoter of
ound healing in the ﬁeld of surgery (Madhumathi et al., 2010;
udheesh Kumar et al., 2010; Wang, Du, Fan, Liu, & Hu, 2005) and
n a number of pharmaceutical preparations, primarily for the pur-
ose of controlled drug delivery (Felt, Buri, & Gurny, 1998; Khan,
eh, & Chng, 2000) such as, mucosal (Freier et al., 2005; Gorbach et
l., 1994; Mwale et al., 2005), buccal (Rabea et al., 2003), and ocular
Wang et al., 2005) delivery of drugs. NPs based on chitin and chi-
osan are developed and used for different biomedical applications
Anitha et al., 2009; Jayakumar, Prabaharan, Nair, & Tamura, 2010).
TCS was investigated in this study for biomedical applications.
iteratures show that the mucoadhesive properties of TCS are
trongly improved in comparison to unmodiﬁed chitosan (Khan et
l., 2000). When compared with other modiﬁed chitosan materi-
ls, TCS has numerous advantageous features such as signiﬁcantly
mproved mucoadhesive and permeation enhancing properties
Kast & Bernkop-Schnürch, 2001). And these polymers possess
ydrophilic properties due to the presence of thiol groups on their
ide chains (Ronny, Brigitta, Adolf, & Andreas Bernkop, 2008), it
s relatively safe and non-toxic (Ronny et al., 2008), its cationic
olyelectrolyte character provides strong electrostatic interaction
ith negatively charged molecules like DNA or drug (Kast and
ernkop-Schnürch, 2001), it displays enzyme inhibitory properties
Ronny et al., 2008). The mucoadhesive property of TCS permits
sustained interaction between the macromolecule being deliv-
red and themembrane epithelia, promotingmore efﬁcient uptake
roperties (Ronny et al., 2008) and it has the ability to open inter-
ellular tight junctions facilitating transport into the cell also via
he basolateral membrane (Ronny et al., 2008). Because of these
avorable properties TCS have been used for drug and gene deliv-
ry (Jayakumar, Chennazhi, et al., 2010; Jayakumar, Deepthy, et al.,
010; Jayakumar, Prabaharan, Nair, & Tamura, 2010; Jayakumar,
rabaharan, Nair, Tokura, et al., 2010).
In the case of thiolated polymers, the actual mechanism of
ermeation enhancement can be explained based on the electro-
tatic interaction between positively charged thiolated polymer
nd negatively charged sites in the tight junctions, which will lead
o drug transport via transiently opened tight junctions. These
olymers can tightly adhere to the intestinal mucus layer for a pro-
onged time through covalent bonding with mucin glycoproteinss of TCS from chitosan using TGA.
via thiol–disulﬁde exchange reactions, hence providing a steeper
drug concentration gradient at the absorption sites and exert-
ing an additional permeation enhancing effect (Bernkop-Schnürch,
Hornof, & Guggi, 2004). Also polymers with thiol groups, so-called
“thiomers” display in situ gelling properties due to the forma-
tion of inter- and intramolecular disulﬁde bonds at physiological
pH values. Recently, it has been shown that polymers with thiol
groups provide much higher adhesive properties than those poly-
mers generally considered to bemucoadhesive (Bernkop-Schnürch
et al., 1999). The enhancement of mucoadhesion can be explained
by the formation of covalent bonds between the polymer and
the mucus layer, which are stronger than non-covalent bonds
(Bernkop-Schnürch et al., 1999).
In this work TCS was developed from chitosan with the help
of TGA. The prepared TCS was characterized by FT-IR and degree
of thiol substitution was found out using Ellman’s protocol. TCS-
NPswerepreparedby ionic cross-linking reaction. Characterization
of the same was done using different characterization techniques.
As a preliminary work before going in to biomedical applications,
cell compatibility studies of the prepared NPs were tested by MTT
assay in different cell lines (both normal and cancer). In addition
cell uptake studies of TCS-NPs were also conducted by rhodamine
conjugation of TCS-NPs.
2. Experimental
2.1. Materials
Chitosan (molecular weight 100–150kDa and degree of
deacetylation 80%) was purchased from Koyo Chemical Co., Ltd.,
Japan, TPP, dialysis tubings (molecular weight cut-off 12kDa),
Triton X-100, EDC and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide] were purchased from Sigma
Aldrich, TGA from Merck, breast cancer cell line (MCF-7), ﬁbrob-
last cell line (L929) and mouse embryonic ﬁbroblast (NIH3T3) for
cell culture experiments were purchased from NCCS, Pune and all
other chemicals used are of analytical grade.
2.2. Synthesis of TCS
TCS was synthesized based on the reported literatures
(Bernkop-Schnürch et al., 1999, 2004; Lichen et al., 2009; Margit
et al., 2003). The reaction scheme for TCS synthesis is shown in
Fig. 1. The coupling reaction of chitosan with TGA was mediated
by a carbodiimide, EDC. Brieﬂy 500mg of chitosan was dissolved
in 50ml 1% acetic acid. Thereafter EDC dissolved in 1ml deminer-
alized water was added to a ﬁnal concentration of 125mM. After
proper mixing of these two, 500mg TGA was added and the pH of
the medium was adjusted to 5. The synthesis was performed at a
pH 5.0, in order to avoid the formation of disulﬁde bonds between
68 A. Anitha et al. / Carbohydrate Polymers 83 (2011) 66–73
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he polymer chains by oxidation during the coupling reaction. At
hat pH, the amount of the reactive form for the oxidation of thiol
roups (thiolate anions) is low and the formation of disulﬁde bonds
an be minimized (Bernkop-Schnürch et al., 2004). Then the reac-
ion mixture was incubated for 4h in dark at room temperature
nder constant stirring. In order to isolate the TCS from the reaction
ixture, the polymer solutions were dialyzed in tubings of cellu-
osemembranewith amolecularweight cut-off of 12kDa for 3 days
n dark against 5mM HCl, then twice against the same medium but
ontaining 1% NaCl to reduce the ionic interactions between the
ationic polymer and the anionic sulfhydryl groups. For maintain-
ng the pH of the medium as 4, the samples were again dialyzed
gainst 5mM HCl for 2 days. Control samples were made in the
amewaywithout adding TGA.Duringdialysis, the sample contain-
rswere kept in dark at 4 ◦C for avoiding the oxidation of sulfhydryl
roups. After dialysis, the samples and controlswere lyophilized by
rying the frozen aqueous polymer. The lyophilized product was
sed for further studies.
.3. Quantiﬁcation of thiol group content (determination of
egree of thiol substitution/determination of free sulfhydryl
roups) by Ellman’s method
The degrees of thiol group substitution in these modiﬁed
olymers were determined spectrophotometrically using Ellman’s
eagent as described in literature (Margit et al., 2003). Ell-
an’s method is based on the reaction of Ellman’s reagent with
ulfhydryl bearing compounds. Ellman’s reagent (5,5′-dithio-bis-2-
itrobenzoic acid or DTNB) is a versatile water-soluble compound
or quantitating free sulfhydryl groups in solution. A solution of this
ompound produces a measurable yellow-colored product when it
eacts with sulfhydryl groups. Consequently, Ellman’s reagent is
ery useful as a sulfhydryl assay reagent because of its speciﬁcity
or –SH groups at neutral pH, DTNB reacts with free sulfhydryl
roups to yield a mixed disulﬁde and 2-nitro-5-thiobenzoic acid
TNB) as shown in Fig. 2. The target of DTNB in this reaction is
he conjugate base (R–S−) of a free sulfhydryl group. Therefore,
he rate of this reaction is dependent on several factors such as
he reaction pH, the pKa of the sulfhydryl and steric and electro-ing Ellman’s method.
static effects. TNB is the ‘colored’ species produced in this reaction
and has a high molar extinction coefﬁcient in the visible range.
Sulfhydryl groups can be estimated in a sample way, by compar-
ing with a standard curve composed of known concentrations of a
sulfhydryl-containing compound such as TGA.
Brieﬂy, a 2mg/ml solution of polymer was prepared in milli-
pore water. Then 250l aliquots were added to 250l of 0.5M
phosphate buffer (pH 8.0) and to 500l of Ellman’s reagent
(0.3mg/ml of DTNB in 0.5mol/l phosphate buffer pH 8.0). The reac-
tion was allowed to proceed for 2h at room temperature and the
absorbancewasmeasured at awavelength of 420nm. Control sam-
ples were elaborated with non-modiﬁed chitosan. The amount of
thiol moieties was calculated from the corresponding standard
curve elaborated between 0.25 and 2mM of thioglycolic acid solu-
tion in water (Bernkop-Schnürch, Kast, & Guggi, 2003).
2.4. Characterization of TCS
FT-IR spectra of chitosan and TCS were recorded on Perkin-
Elmer Spectrum RX1 Fourier transforms infrared spectrophotome-
ter using KBr method. The new amide bond formation and thiol
group substitution in TCS can be conﬁrmed by FT-IR, based on the
presence of the characteristic peaks of newly formed amide bond
and thiol groups.
2.5. Preparation of TCS-NPs
TCS-NPs were obtained as a result of ionic cross-linking reac-
tion with a cross-linker, TPP (Anitha et al., 2009; Devika & Varsha,
2006). The TCS prepared was dissolved in water and kept for stir-
ring. NPs were obtained as result of the addition of TPP solution to
the aqueous solution of polymer; TCS to TPP weight ratio used is
3:1. As a result of ionic cross-linking, a turbid solutionwasobtained,
which was kept for half an hour stirring. The resultant TCS-NPs
were separated from the stable suspension by centrifugation at
13,000 rpm for 1h at 10 ◦C. Then the pellet was redispersed in
water and lyophilized, the lyophilized sample was used for further
characterization and studies.
rate Polymers 83 (2011) 66–73 69
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the ﬂuorescence microscope. The experiment was performed in
triplicates.
Table 1
Cell viability (%) values of NIH3T3, L929 and MCF-7 for the different concentrations
of TCS-NPs.
Concentration (mg/ml) Cell viability (%)
L929 NIH3T3 MCF-7
0 100 100 100
0.0 98.86587 98.85827 99
0.4 98.77119 98.89136 98.8
0.6 98.6685 98.75415 99
0.8 98.47955 98.25249 98.7
1 98.34721 98.84385 98.6A. Anitha et al. / Carbohyd
.6. Characterization of TCS-NPs
.6.1. Measurement of particle size by DLS measurements
The mean size and size distribution of the prepared NPs were
etermined by DLS measurements using DLS-ZP/Particle Sizer
icompTM 380 ZLS.
.6.2. Stability studies—determination of zeta potential
The surface charge and thereby the stability of the TSC-NP
ystem was determined by zeta potential measurements using a
LS-ZP/Particle Sizer NicompTM 380 ZLS.
.6.3. Measurement of particle size and morphology by AFM
The size and morphological characteristics of the prepared TCS-
Ps were further conﬁrmed by AFM (JEOL JSPM-5200). For AFM,
he NP suspension was successively diluted in millipore water and
twas spread on an aluminiumdisc and dried at room temperature.
he resulting sample was used for AFM imaging.
.6.4. FT-IR
In order to conﬁrm the formation of TCS from TGA, i.e. to study
he chemical interaction between each of these constituents, FT-IR
pectrawas takenbyPerkin-ElmerSpectrumRX1Fourier transform
nfrared spectrophotometer using KBr method. The freeze dried
CS-NPs were mixed with KBr and pressed in to a pellet and kept
or scanning.
.6.5. Thermal studies
The thermal behavior of the chitosan, TCS and TCS-NPs were
tudied using TG/DTA analysis. TG/DTA analysis was performed
ith SII TG/DTA 6200 EXSTAR between 20 and 500 ◦C with a
0 ◦C/min heating rate under nitrogen atmosphere. This study was
sed to study the moisture content in each of them and their ther-
al degradation behavior.
.7. Cell culture
L929, NIH3T3 and MCF-7 cell lines were used in this study.
he cells were maintained in minimum essential medium (MEM)
upplemented with 10% fetal bovine serum (FBS). The cells were
ncubated in CO2 incubator at 37 ◦C with 5% CO2. After reach-
ng conﬂuency, the cells were detached from the ﬂask with
rypsin-EDTA. The cell suspension was centrifuged at 3000 rpm
or 3min and then re-suspended in the growth medium for fur-
her studies. After third passage, the cells were split and used for
xperiments.
.8. In vitro cytocompatibility studies
In vitro cytocompatibility of the prepared TCS-NP was done by
TT assay in two normal (L929 and NIH3T3) cell lines and one
ancer cell line (MCF-7). MTT assay is a colorimetric test based
n the selective ability of viable cells to reduce MTT in to pur-
le colored formazan crystals. These formazan crystals have an
bsorbance maxima at 570nm. The formazan crystals produced
ere dissolved in a solubilisation buffer and absorbance was taken
t 570nm. The absorbance obtained is directly proportional to
he number of viable cells. Based on that, a graph was plotted
.e. the percentage cell viability versus TCS-NP concentration in
g/ml.
MTT assay was done for a range of concentrations from 0.2 tomg/ml with normal cell cultured wells without any particles as
egative control. Then theparticles alongwith cellswere incubated
or 48h. Then MTT solution (10%) was added and kept for 4h of
ncubationand thensolubilisationbufferwasaddedandagain incu-
ated for 1h. After complete dissolvation of MTT, the absorbanceFig. 3. FT-IR spectra of chitosan (A) and TCS (B).
was measured at a wavelength of 570nm using a Beckmann Coul-
ter Elisa plate reader (BioTek Power Wave XS). Triplicate samples
were analyzed for each experiment.
2.9. In vitro cell uptake studies
In vitro cell uptake studies of TCS-NP was done by rhodamine
123 conjugation of TCS-NPs. Cell uptake studies were done in two
normal (L929 and NIH3T3) and one cancer cells (MCF-7). For this,
acid etched cover slips were placed in 24 well plates and were
seeded with a density of 10,000 cells per cover slip and incubated
for 24h for the cells to attach. After 24h incubation, the media
was removed and the wells were carefully washed with PBS buffer.
Then the rhodamine 123 conjugated TCS-NPs at a concentration
of 1mg/ml was added along with the media to each of the wells
and incubated for 24h. There after the sample containing media
was removed and the cover slips were dried and processed for
imaging using ﬂuorescent microscopy. The processing involved
washing the cover slips with PBS and thereafter ﬁxing the cells
in 5% paraformaldehyde (PFA) followed by a ﬁnal PBS wash. The
cover slips were air dried and mounted on to glass slides with
DPX as the mountant medium. The slides were then viewed under1.2 98.03924 98.73887 98.8
1.4 98.56 98.92284 98.9
1.6 98.74197 98.81462 98.7
1.8 98.53151 98.96678 98.6
2 98.75591 99.11628 98.9
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. Results and discussion
.1. Preparation and characterization of TCS
TCS was synthesized using TGA as the thiolating moiety and
he characterization was done using FT-IR. TCS was obtained as
result of the formation of amide bond between NH2 groups ofhitosan and carboxyl groups of TGA via EDC catalyzed reaction
nd the new amide bond formation between chitosan and TGA can
e conﬁrmed by FT-IR. The degree of thiol substitution was found
ut using Ellman’s protocol and it was found to be 60%.
Fig. 5. (A) and (B) TGA and DTA of (A) cM images of TCP-NPs .
Fig. 3 represents the combinedFT-IR spectra of chitosan andTCS.
In the spectrum of chitosan, the characteristic absorption peaks
are at about 3410 cm−1 (O–H and N–H), 2924 cm−1 (C–H), 1623,
1513 cm−1 (ıN–H), 1088 cm−1 (C–N), 651 cm−1 (ıNH2), 1380 cm
−1
(ıC–H), 1248 cm−1 (ıO–H), 1153 cm−1 (ıC–O–C), 651 cm−1 (due to
amino groups) and 895 cm−1 (epimeric -ıC–H of cyclic pyranosyl
rings) could be easily observed. In TCS all thepeaks in chitosanwere
present, except the peaks corresponding to amino (NH2) groups,
since amino groups in chitosan were reacted with carboxyl groups
of TGA resulting in an amide bond, so the additional peaks of this
newly formed amide bond and peaks of thiol groups (from the TGA
hitosan, (B) TCS and (C) TCS-NPs.
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oiety) was observed. The wave numbers corresponding to these
re 1524 (amide II band), 1629 (amide I band) and 1250 cm−1 peak
orresponds to thiol groups (Bernkop-Schnürch et al., 1999, 2003,
004).
.2. Preparation and characterization of TCS-NPs
TCS-NPswereobtainedas a result of the ionic cross-linking reac-
ion between the positively charged protonated amine groups of
CS and negatively charged phosphate groups of TPP. By adjust-
ng the concentration of the precursors and stirring speed, we can
ontrol the degree of cross-linking and thus the particle size.
.2.1. Particle size analysis using DLS measurements
Using DLS measurements, the size distributions for the TCS-
Ps were obtained. Fig. 4A shows the particle size distribution for
CS-NPs. The average diameter of the TCS-NPs was found to be
0–100nm.
.2.2. Particle size and morphology studies
The size of thepreparedNPswere also conﬁrmedbyAFM. Fig. 4B
nd C represents the AFM images of TCS-NPs at different magniﬁ-
ations. These particles showed a size range of 80–100nm in AFM.
rom the AFM images, it is clear that the prepared TCS-NPs possess
pherical morphology.
.2.3. Stability of the TCS-NP system by zeta potential
easurements
Surface charge and thereby the stability of the prepared NP sys-
ems was determined by zeta potential measurements. The zeta
otential value for the TCS-NP system was found to be +43.69mV.
his value indicates that the prepared system is extremely stable
nd the TCS-NPs possess positive surface charge. This net positive
urface charge canbeexplainedby thepresenceofmoreprotonated
mino groups in TCS-NPs surface.
.2.4. FT-IR studies
FT-IR spectra of TCS and TCS-NPs were taken, the character-
stic peaks of TCS are at 3410 cm−1 (O–H and N–H), 2924 cm−1
C–H), 1623, 1513 cm−1 (ıN–H), 1088 cm−1 (C–N), 651 cm−1 (ıNH2),
380 cm−1 (ıC–H), 1248 cm−1 (ıO–H), 1153 cm−1 (ıC–O–C), 651 cm−1due to amino groups) and 895 cm−1 (epimeric -ıC–H, of cyclic
yranosyl rings), 1524 (amide II band), 1629 (amide I band) and
250 cm−1 peak corresponds to thiol groups.
In the NPs spectrum, i.e. the TPP cross-linked TCS, all the peaks
f TCS were present, but the intensity of most of them reducedds L929, NIH3T3 and MCF-7.
especially the 1637 peak, this can be explained by the ionic cross-
linking reaction of TPP with N–H groups of TCS that is ultimately
leads toNP formation (Anithaet al., 2009;DevikaandVarsha, 2006).
3.2.5. TG/DT analysis
3.2.5.1. TGA. The thermal degradation behavior of chitosan, TCS
and TCS-NPs are shown in Fig. 5A and B. Fig. 5A represents the
TGA of chitosan, TCS and TCS-NPs. From the ﬁgure it is clear that
chitosan started to degrade at 250 ◦C and has a broad degradation
temperature rangewith ahigh char yield at 550 ◦C. Thedegradation
mechanism is very complex including dehydration, deacetylation
and chain scission. The ﬁrst-stage degradation from 200 to 250 ◦C
was attributed to the loss of water (Trong-Ming, Chung-Yang, &
Wen-Yen, 2002). ForTCS, thedegradation starts at a lower tempera-
ture compared to chitosan. This canbeexplainedby the fact that the
chain scission in the case of TCS is easier because of the presence of
easily breakable side chains (due to thiolation –NH–CO–CH2–SH),
where as in the case of TPP cross-linked TCS i.e. in TCS-NPs degra-
dation is much difﬁcult than TCS, this can be explained by the TPP
cross-linking, this makes the thermal degradation difﬁcult (Khalid,
Agnely, Yagoubi, Grossiord, & Couarraze, 2002).
The DTA curves for chitosan, TCS and TCS-NPs were shown
in Fig. 5B. In all the three curves, an endothermic peak was
observed around a temperature of 200–275 ◦C and exothermic
peaks observed between 270 and 310 ◦C these are characteristics
of chitosan (Khalid et al., 2002).
3.3. In vitro cytocompatibility studies by MTT assay
In vitro cytocompatibility of the prepared TCS-NP was deter-
minedbyMTTassay. The testwasdone for a rangeof concentrations
from 0.2 to 2mg/ml, with normal tissue culture medium without
any NPs as negative control. Fig. 6 shows a plot that describes the
percentage cell viability versus concentration of the NPs in mg/ml.
Table 1 gives the cell viability values in percentage for the respec-
tive cell lines with respect to the concentration of TCS-NPs.
From the plot it was clear that, there is no signiﬁcant difference
in percentage cell viability in any of the concentrations of the NPs
samples studied. Similarly, we also compared the level of toxicity
of NPs with the negative control, which is the normal tissue cul-
ture medium. It was evident from the ﬁgure that compared to the
negative control almost 98% cells are viable in all the different con-
centrations of TC-NPs. These results indicated that the prepared
TCS-NPs are less toxic to breast cancer cells (MCF-7) and normal
cells (L929 and NIH3T3) and this is an essential requirement for a
material to be used for biomedical applications.
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.4. In vitro cell uptake studies using ﬂuorescent imaging
In vitro cellular uptake studies of rhodamine 123 conjugated
CS-NPs were studied by visualizing the bright green ﬂuorescence
oming from the rhodamine dye using ﬂuorescence microscopy.
ig. 7 shows the microscopic images of ﬂuorescence study. Con-
rol cells without any NPs showed no ﬂuorescence. Cells incubated
ith rhodamine conjugated TCS-NPs showed green ﬂuorescence
onﬁrming the internalization of the TCS-NPs inside the cells. Also,
t is evident from the ﬂuorescence images (Fig. 7) that even afterd–f, ﬂuorescent images), NIH3T3 (g–i, bright ﬁeld and j–l, ﬂuorescent images) and
incubation with particles; the cells have retained its normal mor-
phology which further demonstrates the biocompatibility of the
TCS-NP system.4. Conclusions
A mucoadhesive polymer, TCS was synthesized and character-
ized. Degree of thiol substitution was found out using Ellman’s
protocol and it was found to be 60%. The prepared TCS-NPs were
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haracterized using DLS, AFM, FT-IR and TG/DTA studies. The
repared NPs possess a size range of 80–110nm and spherical
orphology. Stability studies were done by zeta potential mea-
urements and the system was found to be extremely stable and
he NPs possess positive surface charge. In vitro cytocompatibility
f the prepared NPs were studied using MTT assay towards nor-
al and cancer cell lines. These results showed that the prepared
Ps are less toxic (almost 98% cells are viable in all the different
oncentrations TCS-NPs samples). So the prepared TCS-NPs can be
sed as an efﬁcient biomaterial for biomedical applications such as
ucoadhesive drug delivery, gene delivery, etc.
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